Penumbra, Inc., was incorporated in 2004 as a Delaware corporation. The company is a global interventional therapy company focused on the design, development, manufacture and sale of innovative medical devices. The company has a broad product portfolio of nerves and peripheral blood vessels to address challenging medical conditions and significant clinical needs across two major markets. Its product addresses include ischemic stroke, hemorrhagic stroke, and various peripheral blood vessels that can be treated through thrombosis and embolization procedures. 

PEN

PEN Profile